Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,030
Total Claims
$924K
Drug Cost
732
Beneficiaries
$1,263
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-91%
Opioid rate vs peers
0.2% vs 2.6% avg
+18%
Cost per patient vs peers
$1,263 vs $1,068 avg
+24%
Brand preference vs peers
11.2% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
22
Opioid Claims
$272
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 991 claims · $760K
Generic: 7,891 claims · $159K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 79 | $111K |
| Insulin Glargine,hum.Rec.Anlog | 87 | $74K |
| Empagliflozin | 45 | $65K |
| Sitagliptin Phosphate | 47 | $63K |
| Rivaroxaban | 37 | $47K |
| Insulin Aspart | 20 | $34K |
| Fluticasone/Umeclidin/Vilanter | 35 | $32K |
| Tiotropium Bromide | 25 | $31K |
| Emtricitabine/Tenofov Alafenam | 12 | $28K |
| Fluticasone/Vilanterol | 31 | $19K |
| Umeclidinium Bromide | 20 | $14K |
| Levothyroxine Sodium | 487 | $10K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $10K |
| Insulin Lispro | 17 | $8,831 |
| Fluticasone Propion/Salmeterol | 15 | $8,370 |
Prescribing Profile
Patient Profile
75
Avg Age
43%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data